Simulations Plus

Second quarter net sales increase 11.8%; net income up 26.5%

Conference Call to be on Wednesday, April 10, at 4:30 PM ET

Revenues Increase 11.7% for New Record Quarter

Net sales increase 1.9% to first-quarter record $2.290 million; Earnings per share $0.04

Company declares accelerated cash dividend of $0.14 per share

Revenues Increase 1.9% for New Record 1st Quarter

Fiscal Year Pharmaceutical Software and Services Up 8.1%, EPS Up 11.1%

Conference Call to be on Monday, November 19, 2012, at 4:15 PM EST

Company declares cash dividend of $0.05 per share

Simulations Plus is the only non-European company invited to consortium

Pharmaceutical Software and Services Revenues Increase 14.9% for Record 4th Quarter, up 8.1% for the Record Fiscal Year

Company declares cash dividend of $0.05 per share

3rd quarter sales increase 5.0% to $2.77 million; 9 months net income up 5.9% to $2.68 million

Conference Call to Be on Thursday, July 12, at 4:15 PM ET

Ms. Anu Sharma Joins the Company as Senior Sales and Marketing Manager, focusing on Cheminformatics Products

Major Pharmaceutical Company to Fund Transdermal and Subcutaneous Drug Absorption Model in GastroPlus

Major Pharmaceutical Company to Fund Enhanced Oral Cavity Model in GastroPlus™

Net sales increase 4.9% to new 3rd quarter record of $2.77 million